Please try another search
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.
Name | Age | Since | Title |
---|---|---|---|
Steven D. Rubin | 64 | 2014 | Independent Vice Chairman |
Phillip Frost | 88 | 2014 | Independent Director |
Baek Kim | - | - | Member of Scientific Advisory Board |
Roland Strong | - | - | Member of Scientific Advisory Board |
Anthony J. Japour | 64 | 2019 | Independent Director |
Bob Lehman | - | - | Member of Scientific Advisory Board |
Richard C. Pfenniger | 69 | 2021 | Independent Director |
Fred Hassan | 78 | 2023 | Independent Director |
Roger D. Kornberg | 77 | 2008 | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review